# NIACIN
> **ANDA213090** · Abbreviated New Drug Application (Generic) · Sponsor: HIBROW HLTHCARE · Approved 2023-08-25
## Drug
- **FDA Application Number:** ANDA213090
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NIACIN
- **Generic name:** Niacin
- **Active ingredients:** NIACIN
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HIBROW HLTHCARE
- **First approval:** 2023-08-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213090)
---
*AI Analytics · CC0 1.0*